https://www.selleckchem.com/pr....oducts/prt062607-p50
To assess safety and efficacy of corneal collagen crosslinking (CXL) for advanced bullous keratopathy (BK). Eight eyes of eight patients subjected to Dresden CXL protocol. BK history of at least one year, severe pain and no indication for keratoplasty due to poor visual prognosis. best corrected visual acuity (BCVA), pain (decimal visual scale), central corneal thickness (CCT) by tomography (Pentacam®, Oculus Inc, Germany), corneal bullae and complications. Seven women and one man of median age 77.00 (range 58-79) years. T
Like
Comment
Share
